The following is a lightly edited transcript of a virtual roundtable discussion recorded in September 2020. To view the full discussion, go to www.mdedge.com/FedPrac/HCC-Roundtable.
Supplements
When First-Line Systemic Treatment for Hepatocellular Carcinoma Fails, What Comes Next?
Publish date: October 30, 2020
Author(s):
Katie Kelley, MD; et al